InsidersTradesSigma
Discover the full insider trade history of Syngene Intl, a publicly traded company based in India. Shares are listed on IN IN, under the oversight of SEBI (PIT + SAST). Market capitalisation: €182.4bn. The latest transaction was reported on 26 May 2026 (Acquisition). Among the most active insiders: Nippon India Mutual Fund. The full history is openly available.
Analysts rate Syngene Intl Buy (bullish), based on 8 analysts. Average price target: ₹578.13.
Informational score on this market. Our backtest validates the signal only on 8 EU venues; elsewhere (notably US markets) insider buys historically invert or do not hold. Not a recommendation.
Transparent value + quality ranking, distinct from the insider signal. See the method
Fundamental view, insider signal, bull and bear case, synthesis.
AI-generated analysis. Opinion, not investment advice. Not backtested. Built from public filings and financials. No price target, no buy or sell recommendation.
2 of 2 declarations